Stockreport

Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE)

Merit Medical Systems, Inc.  (MMSI) 
Last merit medical systems, inc. earnings: 4/23 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: merit.com/investors
PDF  At 6 months, the WRAPSODY CIE achieved 89.8% and 72.6% target lesion primary patency and access circuit primary patency, respectively.At 12 months, the WRAPSODY CIE ach [Read more]